Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

DSGN

Design Therapeutics (DSGN)

Design Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DSGN
DateTimeSourceHeadlineSymbolCompany
03/10/20256:30AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DSGNDesign Therapeutics Inc
03/10/20256:16AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:DSGNDesign Therapeutics Inc
03/10/20256:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
03/10/20256:07AMGlobeNewswire Inc.Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:DSGNDesign Therapeutics Inc
03/03/20257:00AMGlobeNewswire Inc.Design Therapeutics to Participate in Leerink’s Global Healthcare ConferenceNASDAQ:DSGNDesign Therapeutics Inc
02/07/20253:16PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:DSGNDesign Therapeutics Inc
02/07/20253:15PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:DSGNDesign Therapeutics Inc
01/13/20258:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
01/06/20256:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
01/06/20256:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
12/19/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
11/13/20247:00AMGlobeNewswire Inc.Design Therapeutics to Participate in Multiple Upcoming Investor ConferencesNASDAQ:DSGNDesign Therapeutics Inc
11/07/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
11/07/20243:01PMGlobeNewswire Inc.Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM PortfolioNASDAQ:DSGNDesign Therapeutics Inc
09/10/20247:00AMGlobeNewswire Inc.Design Therapeutics to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:DSGNDesign Therapeutics Inc
08/12/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
08/09/20243:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DSGNDesign Therapeutics Inc
08/05/20247:12AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DSGNDesign Therapeutics Inc
08/05/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
08/05/20247:00AMGlobeNewswire Inc.Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACâ„¢ PortfolioNASDAQ:DSGNDesign Therapeutics Inc
06/17/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
06/17/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DSGNDesign Therapeutics Inc
06/17/20243:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
05/08/20243:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DSGNDesign Therapeutics Inc
05/08/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DSGNDesign Therapeutics Inc
05/08/20243:05PMGlobeNewswire Inc.Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program MilestonesNASDAQ:DSGNDesign Therapeutics Inc
05/07/20245:30AMGlobeNewswire Inc.Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:DSGNDesign Therapeutics Inc
03/19/20243:01PMGlobeNewswire Inc.Design Therapeutics Outlines Progress Across GeneTACâ„¢ Platform and Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:DSGNDesign Therapeutics Inc
03/19/20246:27AMIH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:DSGNDesign Therapeutics Inc
03/12/20245:30AMGlobeNewswire Inc.Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio UpdateNASDAQ:DSGNDesign Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DSGN